A Study to Evaluate the Efficacy and Safety of ANB019 in the Treatment of Subjects With Ichthyosis

• Status: Recruiting
• Trial end date: 2023-02-01
• Target enrollment: 0
• Participant gender: All

Summary

Efficacy and Safety of ANB019 in Subjects with Ichthyosis

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AnaptysBio, Inc.

Criteria

Inclusion Criteria:

• Diagnosis of Ichthyosis

• IASI total score ≥ 18, erythema score ≥ 2

• Subject has been using emollient daily for at least 1 week prior to Day 1 and agrees to continue using that same emollient daily at the same frequency throughout the study

Exclusion Criteria:

• A subject with ichthyosis vulgaris, X-linked ichthyosis, or lamellar ichthyosis will be excluded.